As of 2026-02-18, the EV/EBITDA ratio of Deltex Medical Group PLC (DEMG.L) is -5.45. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. DEMG.L's latest enterprise value is 2.32 mil GBP. DEMG.L's TTM EBITDA according to its financial statements is -0.43 mil GBP. Dividing these 2 quantities gives us the above DEMG.L EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 5.9x - 13.5x | 10.0x |
| Forward P/E multiples | 6.0x - 10.1x | 7.6x |
| Fair Price | (0.15) - (0.22) | (0.20) |
| Upside | -737.4% - -999.3% | -913.0% |
| Date | EV/EBITDA |